Tag: Abbott
First patient procedures performed with Abbott’s balloon-expandable TAVI system
Abbott has announced ...
TCT 2024: Drug-eluting resorbable scaffold proves cost effective at one year in LIFE-BTK analysis
A retrospective econo...
Abbott’s Esprit BTK scaffold system given US FDA approval for CLTI treatment
Abbott has announced that...
US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients
The US Food and Drug Admi...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure
Abbott has announced that...
Transcatheter tricuspid valve repair shows promise for reducing heart failure hospitalisations
In JACC: Heart Failur...
CE mark for transcatheter system that uses same clip technology as MitraClip
Abbott has received t...
FDA Breakthrough Device Designation for fully implantable left ventricular assist system
The US Food and Drug ...
Abbott becomes first company in world to have transcatheter mitral implantation device on market
The Tendyne transcatheter...
Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation
Abbott has announced ...
ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip
At the European Socie...
CRT 2019: US FDA approves resting full-cycle ratio for measuring severity of coronary artery blockages
Abbott has announced the ...
TCT 2018: One-year real-world results show Portico TAVI system reduces severe aortic stenosis
According to one-year res...
Abbott launches trial of its Tendyne transcatheter mitral valve implantation device
Abbott has initiated ...
TCT 2017: Advances in device technology needed to improve outcomes with Absorb
Data from the ABSORB ...
MitraClip becomes first approved device for transcatheter mitral valve repair in Japan
Abbott has announced ...
US trial to evaluate safety and efficacy of Amplatzer for patent ductus arteriosus
Abbott has initiated ...
ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations and cost of care
Late-breaking clinica...
Terumo signs to acquire St Jude Medical and Abbott’s vascular closure business
Terumo has reached an agr...
